Reckitt's Brand Shedding: A Strategic Gamble or Risky Bet?

Reckitt is shedding brands like a snake sheds skin, and Wall Street is watching closely. The consumer goods giant behind Dettol and Durex just posted 5.2 per cent revenue growth for 2025, but the real story isn't in the topline figure. It's in what the company is quietly dismantling to achieve it.

The FTSE 100 firm has completed the £3.6bn sale of its Essential Home division to private equity house Advent International, offloading household names like Air Wick and Cillit Bang in a decisive move away from the diversified portfolio model that defined consumer goods companies for the better part of a century. What remains is a drastically leaner operation built around 11 so-called "powerbrands" — a strategic gamble that Reckitt is betting everything on as its traditional Western markets grind to a near-standstill. This is shrink-to-grow capitalism in its purest form.

The question is whether it leaves Reckitt stronger or dangerously exposed.

The geographic split that tells the real story

Strip away the accounting gains from the Essential Home sale — which delivered a £1.2bn pre-tax profit boost — and the operational reality becomes stark. China and emerging markets delivered 14.6 per cent revenue growth, whilst North America managed a paltry 0.2 per cent and Europe actually contracted by 1.4 per cent. That bifurcation isn't unique to Reckitt.

Enjoying this article?

Get stories like this in your inbox every week.

Join the Community

Every Western consumer goods giant is grappling with the same structural problem: developed markets have stopped growing, and emerging markets are increasingly where the action is. But Reckitt's response is notably more aggressive than its peers. Where Procter & Gamble and Unilever continue to hedge their bets across broad portfolios, Reckitt is doubling down on fewer horses.

Operating profit climbed just two per cent to £3.5bn, and whilst the company trumpeted a near-25 per cent expansion in profit margins, much of that improvement stems from the portfolio reshuffling rather than operational excellence. The firm's 'Fuel for Growth' programme has driven fixed costs down to 19.4 per cent of net revenue from roughly 21 per cent the previous year, and Reckitt is targeting sub-19 per cent by the end of 2027. These are meaningful efficiency gains, but they're also table stakes in an industry facing structural margin pressure.

Durex and Dettol carry the load

Within the powerbrand portfolio, the performance splits are revealing. Durex posted 12.5 per cent growth, driven by product innovations like Durex Intensity and what Reckitt describes as "portfolio upgrades" — a euphemism for charging more for premium variants. Dettol grew 11 per cent and is now the company's largest powerbrand, a position that speaks volumes about where consumer spending priorities lie in an age of heightened health consciousness.

What's interesting here is the category resilience. Hygiene and sexual wellness products are proving far more defensible than traditional cleaning brands in mature markets. Air Wick and Cillit Bang, both now in Advent's hands, represent the old model: mass-market cleaning products competing largely on price in saturated Western supermarkets.

Durex and Dettol occupy different territory entirely — one benefits from lingering pandemic-era behaviours, the other from demographic trends and premiumisation.

The decision to retain a 30 per cent stake in Essential Home provides Reckitt with option value if the divested business performs well under private equity ownership, but it also suggests some lingering uncertainty about whether selling was the right call. Private equity firms typically excel at squeezing costs from mature assets; Advent will be betting it can extract more value from these brands than a sprawling public company could.

The conglomerate discount in reverse

Reckitt returned £2.3bn to shareholders in 2025 through dividends and buybacks, with an additional £1.6bn special dividend paid in February following the Essential Home sale completion. That's capital allocation designed to please the City, and it reflects a broader trend among consumer goods companies to shed the conglomerate discount by becoming more focused.

The traditional logic of consumer goods conglomerates was portfolio diversification: if household cleaners struggled, baby formula or cough syrup would pick up the slack. That model delivered steady, if unspectacular, returns for decades. But investors increasingly view diversification as a tax on returns rather than a hedge against volatility.

Chief executive Kris Licht framed the results as validation of the strategy, noting that the company's "geographic footprint, portfolio of powerbrands and focused organisational structure" have strengthened its ability to deliver sustainable growth. That confidence may be warranted, but it's also predicated on those 11 powerbrands continuing to perform in an increasingly competitive and fragmented market.

The risk is plain: a more concentrated portfolio means less room for error. If one or two of those powerbrands hit regulatory headwinds, face new competition, or simply fall out of fashion, Reckitt has fewer cushions to absorb the blow. The £179m in one-off restructuring costs incurred in 2025 won't be the last; organisational transformation of this scale tends to cost more and take longer than anyone initially projects.

Consumer goods companies are facing an uncomfortable truth: their Western home markets have matured to the point of stagnation, and growth now requires either geographic expansion into emerging markets or ruthless focus on premium categories that can still command pricing power. Reckitt is pursuing both simultaneously, but it's doing so with less diversification than any of its major competitors. Whether that makes the company more nimble or simply more vulnerable will become clear over the next few years, as those 11 powerbrands either justify the faith placed in them or expose the folly of putting too many eggs in too few baskets.

More articles by Ross Williams